| Genetic association between sensitivity to warfarin and expression of CYP2C9* 3 DJ Steward, RL Haining, KR Henne, G Davis, TH Rushmore, WF Trager, ... Pharmacogenetics and Genomics 7 (5), 361-367, 1997 | 382 | 1997 |
| Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium B Rivera-Lebron, M McDaniel, K Ahrar, A Alrifai, DM Dudzinski, C Fanola, ... Clinical and Applied Thrombosis/Hemostasis 25, 1076029619853037, 2019 | 260 | 2019 |
| Clinical pharmacokinetics in the 21st century: does the evidence support definitive outcomes? MHH Ensom, GA Davis, CD Cropp, RJ Ensom Clinical pharmacokinetics 34, 265-279, 1998 | 157 | 1998 |
| Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects AK Bence, EB Anderson, MA Halepota, MA Doukas, PA DeSimone, ... Investigational new drugs 23, 39-49, 2005 | 152 | 2005 |
| A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support B George, M Parazino, HR Omar, G Davis, M Guglin, J Gurley, S Smyth Resuscitation 122, 1-5, 2018 | 77 | 2018 |
| Diagnosis and treatment of pulmonary embolism during the coronavirus disease 2019 pandemic: a position paper from the National PERT Consortium RP Rosovsky, C Grodzin, R Channick, GA Davis, JS Giri, J Horowitz, ... Chest 158 (6), 2590-2601, 2020 | 76 | 2020 |
| Dose‐escalation study of ICA‐17043 in patients with sickle cell disease KI Ataga, EP Orringer, L Styles, EP Vichinsky, P Swerdlow, GA Davis, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (11 …, 2006 | 69 | 2006 |
| Comparison of creatinine clearance estimation methods in patients with trauma GA Davis, MHH Chandler American journal of health-system pharmacy 53 (9), 1028-1032, 1996 | 65 | 1996 |
| The implementation of a pulmonary embolism response team in the management of intermediate-or high-risk pulmonary embolism ES Xenos, GA Davis, Q He, A Green, SS Smyth Journal of Vascular Surgery: Venous and Lymphatic Disorders 7 (4), 493-500, 2019 | 55 | 2019 |
| Risk factors for venous thromboembolism in patients with chronic liver disease KA Walsh, DA Lewis, TM Clifford, JC Hundley, Y Gokun, P Angulo, ... Annals of Pharmacotherapy 47 (3), 333-339, 2013 | 39 | 2013 |
| Use of an audience response system to introduce an anticoagulation guide to physicians, pharmacists, and pharmacy students. PJ Trapskin, KM Smith, JA Armitstead, GA Davis American Journal of Pharmaceutical Education 69 (2), 2005 | 37 | 2005 |
| A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia KM Ruf, ES Bensadoun, GA Davis, JD Flynn, DA Lewis Thrombosis and haemostasis 105 (03), 553-559, 2011 | 35 | 2011 |
| A phase I study to investigate the safety, tolerability, and pharmacokinetics of single oral escalating doses of GW572016 in healthy volunteers PA DeSimone, AK Bence, EB Anderson, MA Halepota, DA Smith, ... Proc Am Soc Clin Oncol 21, 94a, 2002 | 33 | 2002 |
| Validation of the Hartford nomogram in trauma surgery patients DL Finnell, GA Davis, CD Cropp, MHH Ensom Annals of Pharmacotherapy 32 (4), 417-421, 1998 | 33 | 1998 |
| Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series KS Smetana, J Dunne, K Parrott, GA Davis, ACS Collier, M Covell, ... Journal of Thrombosis and Thrombolysis 44, 519-524, 2017 | 31 | 2017 |
| Bioavailability of intranasal butorphanol administered from a single-dose sprayer GA Davis, AC Rudy, SM Archer, DP Wermeling American journal of health-system pharmacy 62 (1), 48-53, 2005 | 29 | 2005 |
| Evolution and operation of a pharmacy residency on-call program KM Smith, KA Hecht, JA Armitstead, GA Davis American journal of health-system pharmacy 60 (21), 2236-2241, 2003 | 28 | 2003 |
| Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT) R Annabathula, A Dugan, V Bhalla, GA Davis, SS Smyth, VA Gupta Journal of thrombosis and thrombolysis 51, 217-225, 2021 | 25 | 2021 |
| Serotonin release assay (SRA)-negative HIT, a newly recognized entity: implications for diagnosis and management KA Pandya, EG Johnson, GA Davis, A Padmanabhan Thrombosis research 172, 169-171, 2018 | 23 | 2018 |
| Pharmacology update. Peptic ulcer disease: clinically relevant causes and treatments. RP Mynatt, GA Davis, F Romanelli Orthopedics 32 (2), 2009 | 22 | 2009 |
